Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Artelo Biosciences, Inc. (ARTL) had Return on Equity of 327.52% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-4.17M |
|
-- |
|
-- |
|
$2.79M |
|
$-2.79M |
|
$-1.38M |
|
$-4.17M |
|
$-4.19M |
|
$-4.17M |
|
$-4.17M |
|
$-4.17M |
|
$-4.19M |
|
$-2.79M |
|
$-2.71M |
|
1.03M |
|
1.03M |
|
$1.38 |
|
$1.38 |
|
| Balance Sheet Financials | |
$0.69M |
|
-- |
|
$2.11M |
|
$2.80M |
|
$4.04M |
|
-- |
|
$0.03M |
|
$4.07M |
|
$-1.27M |
|
$-3.31M |
|
$-1.27M |
|
2.02M |
|
| Cash Flow Statement Financials | |
$-8.52M |
|
$-0.06M |
|
$6.87M |
|
$2.34M |
|
$0.60M |
|
$-1.74M |
|
$1.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.17 |
|
-- |
|
-- |
|
-- |
|
-0.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
327.52% |
125.82% |
|
-148.73% |
|
327.52% |
|
$-0.63 |
|
$-8.28 |
|
$-8.28 |
|